Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study-Reference-Cited by-同舟云学术

Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

Published:2020-05-13 Issue:e1 Volume:28 Page:e47-e50
ISSN:2047-9956
Container-title:European Journal of Hospital Pharmacy
language:en
Short-container-title:Eur J Hosp Pharm

Author:

Samartín-Ucha Marisol,Pego-Reigosa Jose Maria,Álvarez-Payero Miriam,Martin-Vila Alicia,Pineiro-Corrales Guadalupe,Rodriguez-Rodriguez Maria,Melero-Gonzalez Rafael Benito,Maceiras-Pan Francisco,Martinez-Reglero Cristina,Mrtinez-Lopez de Castro Noemi

Publisher

BMJ

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference19 articles.

1. Direct medical costs and their predictors in patients with rheumatoid arthritis

2. Medication Compliance and Persistence: Terminology and Definitions

3. Patient Adherence and Medical Treatment Outcomes

4. Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study;Degli Esposti;Clinicoecon Outcomes Res,2014

5. Medication Compliance and Persistence: Terminology and Definitions

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-04-23

2. Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis;Drug Safety;2023-10-31

3. Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol;BMJ Open;2023-10

4. Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab);Rheumatology Science and Practice;2023-06-28

5. Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study;Rheumatology International;2022-11-05